MTSR
Metsera, Inc.Company Information
- Company Name
- Metsera, Inc.
- CIK
- CIK0002040807
- Category
- <br>Emerging growth company
- Ticker: Exchange
- MTSR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- MTSR
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-02-03
- Last sale
- 2025-11-03
- Shares purchased (TTM)
- 5,234,442
- Shares sold (TTM)
- 461
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 8
- Shares outstanding
- 105,030,422
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- —
- Price on filing date
- —
- 1-month reaction
- —
- 3-month reaction
- —
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||
| Cash Equivalents At Carrying Value | 448 | 531 | 588 | 352 | ||||||
| Prepaid Expense And Other Assets Current | 13 | 7 | 6 | 7 | ||||||
| Assets Current | 461 | 538 | 595 | 359 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 1 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | 73 | 75 | 71 | 69 | ||||||
| Goodwill | 23 | 24 | 23 | 22 | ||||||
| Other Assets Noncurrent | 9 | 2 | 2 | 0 | ||||||
| Assets | 568 | 640 | 691 | 451 | ||||||
Liabilities | ||||||||||
| Accounts Payable Current | 20 | 23 | 15 | 21 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 40 | 38 | 31 | 18 | ||||||
| Notes Payable Current | 2 | 0 | 8 | 8 | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 1 | 1 | 1 | ||||||
| Business Combination Contingent Consideration Liability Current | 45 | 41 | 35 | 19 | ||||||
| Liabilities Current | 108 | 102 | 91 | 67 | ||||||
| Deferred Income Tax Liabilities Net | 8 | 8 | 8 | 8 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 1 | 1 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 114 | 79 | 86 | 88 | ||||||
| Liabilities | 230 | 190 | 185 | 164 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | 541 | ||||||
Stockholders Equity | ||||||||||
| Common Stock Value | 0 | 0 | 0 | - | ||||||
| Additional Paid In Capital | 845 | 838 | 834 | 2 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 11 | 14 | 5 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -519 | -402 | -334 | -257 | ||||||
| Stockholders Equity | 337 | 449 | 505 | -254 | ||||||
| Liabilities And Stockholders Equity | 568 | 640 | 691 | 451 | ||||||
| Series Seed Redeemable Convertible Preferred Stock | 0 | 0 | 0 | 0 | ||||||
| Series A Preferred Stock | 0 | 0 | 0 | 0 | ||||||
| Series A One Preferred Stock | 0 | 0 | 0 | 0 | ||||||
| Series B Preferred Stock | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Authorized | 0 | 0 | 0 | 169 | ||||||
| Temporary Equity Shares Issued | 0 | 0 | 0 | 169 | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | 0 | 169 | ||||||
| Temporary Equity Liquidation Preference | - | - | - | 542 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 800 | 800 | 800 | 72 | ||||||
| Common Stock Shares Issued | 105 | 105 | 105 | 15 | ||||||
| Shares Outstanding | 105 | 105 | 105 | 15 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMetsera, Inc. (MTSR) — SEC Financial Statements & Analysis
Metsera, Inc. (MTSR) is a pharmaceutical preparations company, incorporated in DE. Metsera, Inc. trades on Nasdaq as: MTSR. Metsera, Inc. (MTSR)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12. Based on that filing, On profitability, Metsera, Inc. posts a Return on Equity (ROE) of -77.56% and a Return on Assets (ROA) of -46.07%. Per share, it reports EPS of $-2.49, diluted EPS of $-2.49, free cash flow per share of $-1.86, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 4.25x, a quick ratio of 4.13x, working capital of $352.92M, a debt-to-equity ratio of 0.68x, a debt ratio of 0.41, an interest coverage ratio of -1844.69x, free cash flow of $-195.25M (TTM), and net debt of $-446.06M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-2.49
- ROE TTM
- -77.56%
- ROA TTM
- -46.07%
- Debt To Equity
- 0.68x
- Free Cash Flow TTM
- $-195.25M
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Metsera, Inc. in?
Metsera, Inc. (MTSR) operates in the Pharmaceutical Preparations industry.
What exchange does MTSR trade on?
Metsera, Inc. (MTSR) trades on the Nasdaq.
Where is Metsera, Inc. incorporated?
Metsera, Inc. is incorporated in DE.
When was Metsera, Inc. (MTSR)'s most recent SEC filing?
Metsera, Inc. (MTSR)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12.
What is MTSR's EPS (earnings per share)?
Metsera, Inc. (MTSR)'s trailing twelve month EPS is $-2.49 as of 2025-09-30.
What is MTSR's ROE (return on equity)?
Metsera, Inc. (MTSR)'s trailing twelve month Return on Equity (ROE) is -77.56% as of 2025-09-30.
What is MTSR's ROA (return on assets)?
Metsera, Inc. (MTSR)'s trailing twelve month Return on Assets (ROA) is -46.07% as of 2025-09-30.